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2Abstract
Objective: Excess levels of free radicals such as nitric oxide (NO) and superoxide anion (O2-)
are associated with the pathogenesis of endothelial cell dysfunction in diabetes mellitus. This
study was designed to investigate the underlying causes of oxidative stress in coronary
microvascular endothelial cells (CMEC) exposed to hyperglycaemia.
Methods: CMEC were cultured under normal (5.5 mmol/L) or high glucose (22 mmol/L)
concentrations for 7 days. The activity and expression (protein level) of eNOS, iNOS, NAD(P)H
oxidase and antioxidant enzymes, namely, superoxide dismutase (SOD), catalase and glutahione
peroxidase (GPx) were investigated by specific activity assays and Western analyses,
respectively while the effects of hyperglycaemia on nitrite and O2- generation were investigated
by Griess reaction and cytochrome C reduction assay, respectively.
Results: Hyperglycaemia did not alter eNOS or iNOS protein expressions and overall nitrite
generation, an index of NO production. However, it significantly reduced the levels of
intracellular antioxidant glutathione by 50% (p<0.05) and increased the protein expressions
and/or activities of p22-phox, a membrane-bound component of pro-oxidant NAD(P)H oxidase
and antioxidant enzymes (p<0.05). Free radical-scavengers, namely, Tiron and MPG (0.1-1
mol/L) reduced hyperglycaemia-induced antioxidant enzyme activity and increased glutathione
and nitrite generation to the levels observed in CMEC cultured in normoglycaemic medium
(p<0.01). The differences in enzyme activity and expressions were independent of the increased
osmolarity generated by high glucose levels as investigated by using equimolar concentrations of
mannitol in parallel experiments.
Conclusions: These results suggest that hyperglycaemia-induced oxidative stress may arise in
CMEC as a result of enhanced prooxidant enzyme activity and diminished generation of
3antioxidant glutathione. By increasing the antioxidant enzyme capacity CMEC may protect
themselves against free radical-induced cell damage in diabetic conditions.
4Introduction
Nitric oxide (NO) is generated from amino acid L-arginine by a class of enzymes termed as NO
synthases (NOSs) which include two constitutively expressed isoforms, namely, endothelial
NOS (eNOS) and neuronal NOS (nNOS) and an inducible isoform (iNOS) [1, 2]. NO, generated
within healthy endothelium by eNOS, plays pivotal roles in the maintenance of vascular tone [3]
and in the inhibition of leukocyte adhesion [4] and vascular smooth muscle cell (VSMC)
proliferation [5]. The functions and/or integrity of endothelium change in several pathological
conditions including diabetes mellitus leading to a phenomenon called “endothelial dysfunction”,
a hallmark of diabetic vascular complications which is characterised by impaired endothelial cell
function and enhanced anti-haemostatic properties [6]. Current data as to the pathogenesis of
diabetic endothelial cell dysfunction are extremely diverse in that several mechanisms have so
far been proposed to account for this phenomenon. These include inefficient utilisation of
substrate L-arginine by NOS for NO synthesis [7], an abnormal NOS activity due to inadequate
presence of co-factor tetrahydrobiopterin (H4B) [8], concurrent release of endothelium-derived
constricting factor arising from the cyclooxygenase pathway [9] and NO quenching by advanced
glycation end-products (AGEs) [10].
Despite a lack of consensus on the expression and activity of eNOS and therefore generation
of NO in diabetic conditions, an overwhelming body of evidence has in recent years indicated
that reactive oxygen species (ROS) are released at greater levels in diabetic animals and cells
cultured under high glucose conditions [11, 12]. ROS are, in part, also generated as a direct
consequence of constant and prolonged exposure of cells to hyperglycaemia that leads to non-
enzymatic glycation of plasma proteins [13]. The glycated products undergo further spontaneous
reactions to produce free radicals including superoxide anion (O2-), the foundation radical [14].
5O2- is also formed through the reduction of molecular oxygen by several enzymes such as
cyclooxygenase, xanthine oxidase, mitochondrial NADH dehydrogenase, NOSs and NAD(P)H
oxidase [15, 16]. Amongst these enzymes NAD(P)H oxidase has attracted much of the attention
in recent years and has been characterised in coronary microvascular endothelial cells (CMEC)
as the main source of ROS [17]. It has also been associated with oxidative stress-mediated
endothelial dysfunction in the central retinas of type II diabetic rats [18]. NAD(P)H oxidase,
consists of a membrane-bound cytochrome b558 that in turn consists of p22-phox and gp91-phox,
and several cytosolic subunits, namely, p47-phox, p67-phox, p40-phox and small GTP-binding
protein rac [19]. The importance of p22-phox subunit for the activity and stability of the enzyme
as a whole has been further emphasised by a recent study in that polymorphism of the p22-phox
gene has been linked to initiation and progression of atherosclerotic disease [20].
Under physiological conditions O2- is converted to hydrogen peroxide (H2O2), another ROS,
by superoxide dismutases (SODs), namely CuZn-containing (CuZn-SOD) or Mn-containing
isoform (Mn-SOD) (21). Once generated, H2O2 is metabolised to H2O by enzymatic activities of
catalase and glutathione peroxidase (GPx) [21]. However, in the absence of adequate levels of
SODs or intracellular antioxidants such as glutathione [22], O2- rapidly scavenges NO within the
vascular wall to reduce its biological half-life and causes contraction of vascular smooth muscle
[23, 24]. Indeed, diminished levels of glutathione have been reported in aortic endothelial cells
from diabetic rabbits [25] but not in human umbilical vein endothelial cells cultured in 20
mmol/L glucose for 14 days [26]. It is noteworthy in this context that hyperglycaemia may lead
to glycosylation of SOD enzymes thereby rendering them inactive and consequently elevating
O2- levels [27]. In support of this hypothesis, a recent study has shown that pretreatment with
SOD enhances basal and agonist-stimulated endothelium-dependent vascular relaxant responses
6in diabetic rat aorta therefore suggesting an ample presence of O2- in diabetic tissues [28]. It is
possible that pathologies in the regulation of catalase and GPx, H2O2-scavenging enzymes, may
further complicate the oxidative stress status in diabetes and indeed account for its aetiology.
Hence, the current study was designed to investigate the underlying causes of coronary
endothelial cell oxidative stress in hyperglycaemic conditions with reference to: 1- availability of
intracellular antioxidant glutathione and nitrite, a stable end-product of NO; 2- expression and/or
activity of enzymes that may be involved in the regulation of cellular oxidative stress i.e. eNOS,
iNOS, SODs, GPx and catalase, NAD(P)H oxidase.
Materials and Methods
Isolation and Characterisation of CMEC
The hearts were mounted and perfused retrogradely on a constant-flow Langendorff system
with 0.04% collagenase. The ventricles were then chopped and collagenase digestion was
quenched by the addition of bovine serum albumin to the perfusate. CMEC were obtained by
sedimentation of myocytes and incubated in 0.01% trypsin at 37°C for the prevention of non-
endothelial cell attachment. Cells were then activated by washing in calcium and suspended in
Medium 199 (Gibco-BRL) supplemented with 10% foetal calf serum, 10% newborn calf serum,
benzylpenicillin 250 U/ml, streptomycin 250 g/ml, amphotericin B 12.5 g/ml and gentamycin
50 g/ml. Cell suspensions were plated and incubated at 37°C under 5% CO2. After 1 h
incubation, unattached cells were washed off with saline and remaining cells were cultured to
confluence.
For the different experiments, CMEC were cultured for 7 days in the growth medium
containing either 5.5 mmol/L (normal) or 22 mmol/L (high) D-glucose. When there was a
statistically significant difference between 5.5 mmol/L and 22 mmol/L D-glucose, CMEC were
7also cultured in the presence of 5.5 mmol/L D-glucose + 16.5 mmol/L L-glucose and 5.5 mmol/L
D-glucose + 16.6 mmol/L mannitol to investigate the involvement of extracellular glycation and
increased osmolarity, respectively in the differences. Growth medium was changed on a daily
basis and all experiments were performed on CMEC up to and including passage number 5.
Cultured CMEC were characterised by their typical "cobblestone" morphology and and their
ability to form capillary-like tubes on the Matrigel [29].
Western Blotting
Total cellular proteins were isolated by lysis of CMEC with a boiling solution containing 1%
SDS, 10 mmol/L Tris pH 7.4. Equal amounts of protein were run on 10% SDS-polyacrylamide
gels and transferred onto nitrocellulose membranes. The membranes were then incubated
overnight with either monoclonal (for eNOS, iNOS and p22-phox antibodies from Transduction
Labs.) or polyclonal primary antibodies raised against rat Cu/Zn-SOD, rat Mn-SOD
(Calbiochem) or bovine catalase (Chemicon). Horseradish peroxidase-linked secondary
antibodies were then used and the bands were detected by use of a chemiluminescence agent
(Amersham Pharmacia). Blots were assessed by densitometry of bands with subtraction of the
background counts measured outside loaded lanes. Since, a species-specific antibody for GPx
protein could not be obtained, Western analyses for this protein were not performed.
Nitrite Detection
Nitrite levels were measured by Griess reaction as an index of NO generation following
conversion of nitrate to nitrite by nitrate dehydrogenase [30]. An aliquot of the cellular
homogenate was mixed with an equal volume of Griess reagent (sulfanilamide 1% w/v,
naphthylethylenediamine dihydrochloride 0.1% w/v and orthophosphoric acid 2.5% v/v) and
incubated at room temperature for 10 min prior to measurement of absorbances at 540 nm. The
8amount of nitrite formed was compared to those of known concentrations of sodium nitrite and
normalised to the protein content of the respective flask.
Superoxide anion (O2-) Production
O2- was measured by cytochrome C reduction assay. Briefly, CMEC grown under
normoglycaemic or hyperglycaemic conditions at the density of 5 X106 cells/ml were incubated
with 50 µmol/L cytochrome C for 30 min at 37 °C in Hepes buffer. Absorbances were recorded
using a Cobas-Fara centrifugal analyser at 550 nm with 90 seconds intervals for 12 min.
Production of O2- was calculated as previously described and results were expressed as pmoles
O2- per 106 cells [31].
SOD Assay
SOD activity was also measured by a reaction dependent upon the inhibition of cytochrome C
by endogenous SOD in cellular homogenates using a Cobas Fara centrifugal analyser. The O2-,
required for reduction, was generated by a reaction of xanthine-xanthine oxidase (XO). One unit
of XO activity was defined by the amount of homogenate required to inhibit, by 50%, the rate of
cytochrome C reduction. For assay of total SOD activity, 0.1 mmol/L xanthine was dissolved in
50 mmol/L NaCO3 buffer. A dilute stock solution was added to a 10 mol/L solution of
cytochrome C, 50 mol/L xanthine, 0.1 mmol/L EDTA and 50 mmol/L sodium carbonate to
produce a change in absorbance of 0.0250/min at 550 nm at pH 10. This was followed by the
measurement of Mn-SOD activity, which is resistant to incubation at room temperature with 3
mmol/L potassium cyanide (BDH Chemicals Ltd) for 45 minutes. For Mn-SOD activity the
protocol was identical except that carbonate buffer was replaced with 50 mmol/L potassium
phosphate and pH adjusted to 7.8. CuZn-SOD activity was subsequently calculated by the
subtraction of Mn-SOD activity from total SOD activity.
9Catalase Assay
The activity of catalase was determined by a photometric method where the activity was
determined by monitoring the decomposition of H2O2 at 240 nm in the presence of methanol
which produces formaldehyde which in turn reacts with Purpald (4-amino-3-hydazino-5-
mercapto-1,2,4-triazole) and potassium periodate to produce a chromophore. Quantification was
performed in comparison to the results obtained with catalase and formaldehyde standards.
GPx Assay
The activity of GPx was determined in cellular homogenates using a method developed by
McMaster et al [32]. riefly, a fresh solution containing 0.3 U/ml glutathione reductase, 1.25
mmol/L reduced glutathione and 0.19 mmol/L NADPH in 50 mmol/L potassium buffer (pH 7.4)
was prepared. Homogenates of 100 g total protein were added to this solution and incubated for
3 minutes prior to addition of 12 mmol/L t-butylhydroperoxide to commence the reaction.
Absorbances were read at 340 nm for 4 min. Activities were calculated as nmole glutathione/mg
protein/min.
Glutathione Assay
A modified technique of Griffith was used to measure both reduced (GSH) and oxidized
(GSSG) glutathione levels using a Cobas Fara centrifugal analyser [33]. To detect GSSG,
samples were treated with 2-vinylpyridine that effectively inhibited GSH. Due to low abundance
of GSSG, CMEC were pooled from at least eight T75 flasks prior to analysis.
Cell Viability Assay
A small aliquot of CMEC grown under different conditions was incubated in 0.1% trypan blue
for 3-4 min and viewed under a light microscope. Dead cells were permeable to trypan blue and
thus become coloured. By counting 100 cells, the percentage of viable cells was calculated.
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Statistical Analysis
Results were presented as mean ± SEM. Statistical analysis was performed by a Student's t-
test and P <0.05 was considered statistically significant.
Results
Effects of hyperglycaemia on eNOS, iNOS, p22-phox and antioxidant enzyme protein
expressions
The treatment of CMEC with high glucose concentrations (22 mmol/L) failed to alter eNOS
and iNOS protein expressions but significantly increased p22-phox, CuZn-SOD, Mn-SOD and
catalase protein levels (P<0.05 for each protein) as assessed by Western analyses (Fig. 1). The
differences in protein expression were independent of both extracellular glycation and the
increase in osmolarity as equimolar concentrations of L-glucose and mannitol did not alter the
level of protein expressions, respectively (data not shown).
Effects of hyperglycaemia on nitrite and O2- generation and antioxidant enzyme activities
In accordance with the observed increases in protein expression, hyperglycaemia enhanced the
O2- generation (P<0.05) and activities of CuZn-SOD, Mn-SOD, catalase and GPx (P<0.05 for
each enzyme). However, it failed to change the levels of nitrite production compared to CMEC
cultured under normoglycaemic conditions (P>0.05). Equimolar concentrations of L-glucose or
mannitol did not have any impact on enzyme activities or nitrite generation as compared to cells
grown under normoglycaemic conditions (P>0.05) (Table 1).
Effects of free radical scavengers on nitrite and O2- generation and antioxidant enzyme
activities
Concurrent incubation of CMEC with 22 mmol/L glucose plus one of the free radical
scavengers, namely, mercaptopropionylglycine (MPG, 0.1 -1 mol/L) or Tiron (0.1 -1 mol/L)
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reduced antioxidant enzyme activity to the levels observed in CMEC cultured with 5.5 mmol/L
glucose (P<0.05). These treatments significantly increased nitrite generation and diminished O2-
availability in a dose-dependent manner (P<0.05). These alterations were not observed in CMEC
cultured in equimolar mannitol (Table 2).
Effects of hyperglycaemia on intracellular glutathione levels
Exposure of CMEC to high glucose levels (22 mmol/L) resulted in a significant decrease in
both GSH and GSSG levels compared to CMEC grown in equimolar mannitol or
normoglycaemic conditions (P<0.01). However, treatment of CMEC with 1 mol/L
concentration of either Tiron or MPG significantly increased glutathione levels (P<0.01) (Table
3).
Effects of hyperglycaemia on CMEC viability
There were no significant differences in CMEC viability between cells cultured in different
concentrations of glucose as assessed by trypan blue exclusion assay. Approximately 858% vs
795% of normoglycaemic and hyperglycaemic cells were viable, respectively (P>0.05).
Discussion
The endothelium synthesises and/or releases a wide variety of substances including
angiotensin II, prostacyclin and NO in response several chemical, physical and humoral stimuli
[6]. Because of their ability to release several vasoactive agents and their strategic localisation, as
they constitute the first port of call for any exogenous or endogenous insult, it was critical to
study the response of endothelial cells in relation to pathogenesis of hyperglycaemia-induced
oxidative stress. NO, the most potent endothelium-derived vasodilator, plays pivotal roles in the
maintenance of normal vascular tone, in the modulation of inflammatory and immune responses
and in the inhibition of low-density lipoprotein oxidation, VSMC proliferation and leukocyte
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migration and adhesion [3 – 5]. Three isoforms of NOSs have been characterised to date, all of
which are the products of separate genes and are divided into two classes with respect to their
requirement of Ca2+ for their enzymatic activity [34]. The isoforms originally found in
endothelial cells (eNOS) and in neuronal cells (nNOS) are constitutively expressed and require
Ca2+ for their activity while an inducible isoform (iNOS) is solely expressed in response to
several stimuli including cytokines and does not require Ca2+ for its enzymatic activity [1, 2].
Although eNOS is constitutively expressed, many pathological stimuli like genetic hypertension
[35] regulate its expression. However, the activity and expression of eNOS therefore eNOS-
mediated generation of NO remain rather controversial under many other pathological states
such as diabetes mellitus, a metabolic disorder characterised by hyperglycaemia. Indeed, both
enhanced and diminished expression of eNOS and production of NO has so far been reported in
patients with diabetes mellitus, in animal models of diabetes and in cells cultured under high
glucose conditions [7, 11, 12, 36, 37].
In contrast to eNOS, iNOS produces greater amounts of NO that may lead to cell damage,
inflammation, atherosclerosis and myocardial dysfunction in diabetic conditions [38, 39]. Indeed,
the inhibitors of iNOS namely, aminoguanidine and NOX-101 have been shown to be beneficial
in preventing diabetic vascular permeability and endothelial dysfunction thereby indicating the
significance of iNOS-mediated generation of NO in disease settings [40, 41]. In the current study
nitrite production, a stable end-product of NO, has been shown to be similar in CMEC cultured
with normal (5.5 mmol/L) and high (22 mmol/L) glucose concentrations for 7 days thus
suggesting similar rate of expression for both potential NO-generating enzymes. In order to
substantiate this hypothesis, the levels of eNOS and iNOS protein expressions were investigated.
Our findings have shown a similar degree of protein expressions for both enzymes and similar
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rates of cell viability in CMEC grown under aforementioned conditions. Taken together these
data suggest that alteration in NO levels cannot account, at least during the duration of our
experiments, for the vascular changes and endothelial cell dysfunction.
The amount of functional NO is also determined by the availability of free radicals in
particular O2- which rapidly scavenges NO to reduce its biological half-life, causes contraction of
VSMC and diminishes Ca2+ signals [23, 24]. At lower concentrations, free radicals modulate an
endothelium adaptation to ensure endothelial vasomotion control while at higher concentrations
they affect several intracellular pathways such as kinases, phosphatases and transcription factors
such as NFB and AP-1. The activation of these pathways may subsequently lead to endothelial
barrier disruption, cell lysis potentially by producing other potent free radicals like the hydroxyl
radical catalysed by iron during the Fenton reaction [42].
NAD(P)H oxidase has recently been shown as the main source of free radicals in rat CMEC
where the contributions of other O2--generating enzymes including cyclooxygenase, xanthine
oxidase and NOSs to oxidative stress were found to be negligible using the selective inhibitors of
these enzymes [17]. Hence, in the present study the levels of O2- and the expression of p22-phox
protein, a membrane-bound component of NAD(P)H oxidase that plays a central role in the
activity and stability of the whole enzyme complex [19], were investigated in CMEC cultured in
normoglycaemic and hyperglycaemic medium. The results have revealed a marked increase in
both O2- production and expression of p22-phox protein in CMEC cultured under high (22
mmol/L) glucose concentrations. In support of the current data the previous studies have shown
NAD(P)H oxidase-mediated increases in O2- levels in both diabetic rat aorta and endothelial cells
grown under hyperglycaemic conditions [11, 12]. It is noteworthy that ROS may also be
generated as a direct consequence of constant and prolonged in vivo or in vitro exposure of cells
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to hyperglycaemia [13, 14]. This process leads to protein kinase C activation and non-enzymatic
glycation of plasma proteins which then undergo further spontaneous reactions resulting in the
excess production of ROS like O2-. Many other biochemical pathways associated with
hyperglycaemia e.g. polyol pathway and eicosanoid synthesis may also increase the production
of O2- [13, 14].
In the present study, the relationship between free radicals and coronary endothelial cell
dysfunction was further investigated by use of one of the two structurally distinct O2--scavengers
namely, Tiron and MPG. Both agents have been shown to be beneficial in ameliorating
endothelial cell oxidative stress in that they significantly reduced the elevated levels of O2- and
increased the levels of nitrite in CMEC cultured in high (22 mmol/L) glucose concentrations in a
dose-dependent manner. This finding was in good agreement with a previous study showing that
free radical scavengers and antioxidant agents like probucol alleviate endothelial cell dysfunction
in the abdominal aorta of diabetic rats [43]. These results may suggest a potential role for ROS-
scavengers in eNOS gene regulation in addition to their well-known free radical-scavenging
effects.
The rise in glucose concentration has been associated with a concurrent marked decrease in
both oxidised (GSSG) and reduced (GSH) glutathione levels in CMEC that was reversed by the
addition of either Tiron (1 mol/L) or MPG (1 mol/L). Glutathione is a key aqueous phase
antioxidant in cells and its depletion has been previously reported in retinal pericytes [22] and
endothelial cells [25] cultured in high glucose concentrations where increases in
malondialdehyde as well as CuZn-SOD and Mn-SOD mRNA levels were also reported.
Although the underlying mechanisms of glutathione depletion remain to be determined in full,
decreases have been reported in the gene expression and activity of -glutamyl cysteine
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synthetase (-GCS), the rate-limiting enzyme in glutathione synthesis, with high glucose
concentrations [44]. Moreover, glucose-derived modification of this enzyme has been implicated
in the predisposition of erythrocytes to oxidative stress thereby implying the possibility that a
similar mechanism could also be responsible for decreased glutathione in CMEC which would
predispose them to oxidant-mediated damage [45]. However, it is also possible that free radicals
rather than glucose per se may account for inactivation of -GCS.
Hyperglycaemic-oxidative stress may be further exacerbated by the inactivation or deficiency
of SODs that metabolise O2- to H2O2 (21), another ROS that causes irreversible endothelial
damage linked with diminished NO and is detoxified to H2O by either catalase or GPx [21]. If
H2O2 is not dismutated sufficiently, then excess H2O2 is converted to toxic hydroxyl radicals
through the Fenton reaction [42]. Thus, investigating the high glucose-induced changes in
antioxidant enzyme expression and activities was an appropriate way to elucidate
hyperglycaemia-related oxidative injuries in vitro. We have found in the current study that
hyperglycaemia elicits significant increases in Mn-SOD, CuZn-SOD, GPx and catalase protein
expression and/or activity in rat CMEC. The increases in antioxidant enzyme activities were in
keeping with their well-known induction in response to oxidative stress and have also been
previously reported in human endothelial cells [46] and in patients with type II diabetes mellitus
[47]. In contrast to these reports, a recent study has shown that gene transfer of eNOS but not
CuZn-SOD failed to improve the endothelium-dependent vascular relaxation in carotid arteries
from diabetic rabbits [48]. This may be explained by either inability of CuZn-SOD to penetrate
to vascular smooth muscle layer or by hyperglycaemia-induced glycosylation and therefore
inactivation of SOD enzymes [27]. In support of these hypothesis, a recent study has shown that
pretreatment with cell-permeable SOD enhances basal and agonist-stimulated endothelium-
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dependent vascular relaxant responses in diabetic rat aorta [28]. It therefore appears reasonable
to hypothesise that elevated expression and/or activity of antioxidant enzymes is an adaptive
response of CMEC to meet the biological demand exerted by hyperglycaemic oxidative stress.
Although the current study did not investigate the underlying causes of the increases in
antioxidant gene expression, a recent study has revealed that transcriptional, translational and
post-translational regulations as major determinants of local antioxidant enzyme levels in the
renal cortex of diabetic rats [49].
In conclusion, the current study has shown that the aetiology of hyperglycaemia-induced
oxidative stress in CMEC is multi-factorial. Endothelial cell dysfunction is associated with
increased O2- production as opposed to inadequate synthesis of NO thereby suggesting the idea
that decreasing O2- levels may have beneficial therapeutic implications. By increasing the
antioxidant enzyme capacity, CMEC may equip themselves better protected against free radicals-
induced cell damage in diabetic conditions.
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Figure Legends
Fig. 1. (A) Representative Western blots showing the protein expression of endothelial nitric
oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), p22-phox, CuZn-SOD, Mn-SOD
and catalase in CMEC cultured under normoglycaemic (lanes 1; 5.5 mmol/L) and
hyperglycaemic (lanes 2; 22 mmol/L glucose) conditions for 7 days. (B) Histogram showing the
fold differences in protein expression observed in CMEC cultured under hyperglycaemic versus
normoglycaemic conditions. Data are expressed as mean ± SEM, n=3, * P< 0.05,
normoglycaemic vs hyperglycaemic conditions.
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Table 1 Effect of glucose on nitrite and O2- production and antioxidant enzyme activities.
Nitrite
(nmol/mg protein)
O2- levels
(pmoles/106 cells)
CuZn-SOD
(mU/mg protein)
Mn-SOD
(mU/mg protein)
Catalase
(U/mg protein)
GPx
(mU/mg protein)
NG 12.13 ± 0.61 45 630 ± 110 80 ± 20 4.12 ± 0.86 236 ± 47
HG 13.31 ± 0.66 98* 960 ± 130* 170 ± 40* 7.12 ± 0.93* 555 ± 59*
Control 12.39 ± 0.66 42 670 ± 110 70 ± 23 3.69 ± 0.73 246 ± 41
NG, 5.5 mmol/L glucose; HG, 22 mmol/L glucose; Control, NG + 16.5 mmol/L mannitol. The levels of nitrite, O2- and antioxidant
enzyme activities in CMEC cultured in NG, HG or Control medium for 7 days were measured as described in the Materials and
Methods. Results are expressed as means means s.e.m. from 4 separate experiments. *P<0.05 difference compared to NG group.
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Table 2 Effects of free-radical scavengers, Tiron and MPG, on nitrite and O2- levels and antioxidant enzyme activities.
Nitrite
(nmol/mg protein)
O2- levels
(pmoles/106 cells)
CuZnSOD
(mU/mg protein)
MnSOD
(mU/mg protein)
Catalase
(U/mg protein)
GPx
(mU/mg protein)
NG 12.13 ± 0.61 45 630 ± 110 80 ± 20 4.12 ± 0.86 236 ± 47
HG 13.31 ± 0.66 98* 960 ± 130* 170 ± 40* 7.12 ± 0.93* 555 ± 59*
NG + 1 µM MPG 13.42 ± 0.76 38 580 ± 60 60 ± 10 4.74 ± 0.81 216 ± 31
NG + 1 µM Tiron 13.77 ± 0.81 41 595 ± 55 60 ± 12 4.38 ± 0.60 222 ± 33
HG + 0.1 µM MPG 18.81 ± 1.01*† 63*† 660 ± 110 100 ± 21 4.96 ± 0.81 261 ± 42
HG + 1 µM MPG 20.61 ± 1.21*† 41† 490 ± 70 60 ± 9 3.78 ± 0.69 201 ± 17
HG + 0.1 µM Tiron 18.23 ± 0.96*† 57*† 715 ± 105 110 ± 30 4.77 ± 0.88 312 ± 52
HG + 1 µM Tiron 20.99 ± 1.09*† 39† 520 ± 100 65 ± 10 4.11 ± 0.66 223 ± 38
NG, 5.5 mmol/L glucose; HG, 22 mmol/L glucose. The levels of nitrite, O2- and antioxidant enzyme activities were measured in
CMEC cultured in NG or HG medium for 7 days in the absence and presence of free-radical scavengers, Tiron and MPG. Results
were expressed as means s.e.m. from 4 separate experiments. *P<0.05 difference compared to NG group, † P<0.05 difference
compared to HG group.
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Table 3 Effect of glucose and free radical-scavengers, Tiron and MPG on
reduced (GSH) and oxidised glutathione (GSSG) levels.
GSSG (nmol/mg protein) GSH (nmol/mg protein)
NG 0.064 ± 0.009 2.26 ± 0.28
HG 0.029 ± 0.004* 1.23 ± 0.13*
Control 0.068 ± 0.008 2.17 ± 0.23
HG + 1 µM Tiron 0.071 ± 0.007† 2.47 ± 0.32†
HG + 1 µM MPG 0.073 ± 0.010† 2.26 ± 0.21†
NG, 5.5 mmol/L glucose; HG, 22 mmol/L glucose. Results were expressed as
means s.e.m. from 4 separate experiments. *P<0.05 difference compared
to NG group, †P<0.05 difference compared to HG group.
